The aberrant expression of bone morphogenetic protein 12 (BMP-12) in human breast cancer and its potential prognostic value

Gene Therapy and Molecular Biology

Volumn 13, Issue 1, 2009, Pages 186-193

  Li, Jin ^a   Ye, Lin ^a   Parr, Christian ^a   Douglas Jones, Anthony ^a   Kynaston, Howard G ^a   Mansel, Robert E ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Bone morphogenetic protein 12 and breast cancer

Indexed keywords

EID: 70350782387     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Alarmo, E. L., Korhonen, T., Kuukasjarvi, T. et al, (2008) Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann Oncol 19, 308-14.
2. Alarmo, E. L., Kuukasjarvi, T., Karhu, R. and Kallioniemi, A. (2007) A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 103, 239-46.
3. Alarmo, E. L., Rauta, J., Kauraniemi, P. et al, (2006) Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes Chromosomes Cancer 45, 411-9.
4. Bobinac, D., Maric, I., Zoricic, S. et al, (2005) Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat Med J 46, 389-96.
5. Bokobza, S., Ye, L., Kynaston, H., Mansel, R. E. and Jiang, W. G. (2009) Reduced expression of BMPR-IB correlates with poor prognosis and increased proliferation of breast cancer cells. Cancer Genomics Proteomics in press.
6. Buijs, J. T., Henriquez, N. V., van Overveld, P. G. et al, (2007) Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res 67, 8742-51.
7. Davies, S. R., Watkins, G., Douglas-Jones, A., Mansel, R. E. and Jiang, W. G. (2008) Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance. J Exp Ther Oncol 7, 327-38.
8. Hanavadi, S., Martin, T. A., Watkins, G., Mansel, R. E. and Jiang, W. G. (2007) The role of growth differentiation factor-9 (GDF-9) and its analog, GDF-9b/BMP-15, in human breast cancer. Ann Surg Oncol 14, 2159-66.
9. Helms, M. W., Packeisen, J., August, C. et al, (2005) First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer. J Pathol 206, 366-76.
10. Itoh, S., Itoh, F., Goumans, M. J. and Ten Dijke, P. (2000) Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem 267, 6954-67.
11. Jemal, A., Siegel, R., Ward, E. et al, (2008) Cancer statistics, 2008. CA Cancer J Clin 58, 71-96.
12. Jiang, W. G., Davies, G., Martin, T. A. et al, (2005) Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 11, 6012-9.
13. Kang, H., Watkins, G., Parr, C. et al, (2005) Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 7, R402-10.
14. Katsuno, Y., Hanyu, A., Kanda, H. et al, (2008) Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27, 6322-33.
15. Lee, K. J., Mendelsohn, M. and Jessell, T. M. (1998) Neuronal patterning by BMPs: a requirement for GDF7 in the generation of a discrete class of commissural interneurons in the mouse spinal cord. Genes Dev 12, 3394-407.
16. Lo, L., Dormand, E. L. and Anderson, D. J. (2005) Lateemigrating neural crest cells in the roof plate are restricted to a sensory fate by GDF7. Proc Natl Acad Sci U S A 102, 7192-7.
17. Maloul, A., Rossmeier, K., Mikic, B., Pogue, V. and Battaglia, T. (2006) Geometric and material contributions to whole bone structural behavior in GDF-7-deficient mice. Connect Tissue Res 47, 157-62.
18. Martin, T. A., Parr, C., Davies, G. et al, (2003) Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24, 1317-23.
19. Mikic, B., Ferreira, M. P., Battaglia, T. C. and Hunziker, E. B. (2008) Accelerated hypertrophic chondrocyte kinetics in GDF-7 deficient murine tibial growth plates. J Orthop Res 26, 986-90.
20. Morotome, Y., Goseki-Sone, M., Ishikawa, I. and Oida, S. (1998) Gene expression of growth and differentiation factors-5, -6, and -7 in developing bovine tooth at the root forming stage. Biochem Biophys Res Commun 244, 85-90.
21. Ozkaynak, E., Rueger, D. C., Drier, E. A. et al, (1990) OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. Embo J 9, 2085-93.
22. Parr, C., Watkins, G. and Jiang, W. G. (2004) The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med 14, 779-86.
23. Raida, M., Clement, J. H., Ameri, K. et al, (2005) Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death. Int J Oncol 26, 1465-70.
24. Shi, Y. and Massague, J. (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700.
25. Storm, E. E., Huynh, T. V., Copeland, N. G. et al, (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368, 639-43.
26. Wozney, J. M., Rosen, V., Byrne, M. et al, (1990) Growth factors influencing bone development. J Cell Sci Suppl 13, 149-56.
27. Wozney, J. M., Rosen, V., Celeste, A. J. et al, (1988) Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-34.
28. Ye, L., Lewis-Russell, J. M., Kyanaston, H. G. and Jiang, W. G. (2007) Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol 22, 1129-47.